| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Bailey Evan Prescott | Chief Medical Officer | C/O APPLIED THERAPEUTICS, INC., 545 FIFTH AVENUE, SUITE 1400, NEW YORK | /s/ Leslie D. Funtleyder, as attorney-in-fact | 17 Jun 2025 | 0002071667 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | APLT | Common Stock | 541,669 | 15 Jun 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | APLT | Stock Option (Right to Buy) | 15 Jun 2025 | Common Stock | 19,531 | $1.50 | Direct | F1 | ||||||
| holding | APLT | Stock Option (Right to Buy) | 15 Jun 2025 | Common Stock | 4,883 | $1.50 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | These options are fully vested. |
| F2 | Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option vested on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date. |